Bloch P. Kathleen's Insider Trades & SAST Disclosures
Bloch P. Kathleen's most recent trade in Cytosorbents Corp was a trade of 87,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bloch P. Kathleen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 87,000 | 87,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 65,000 | 532,941 (1%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 49,038 | 49,038 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Bloch Kathleen P. | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 37,594 | 467,941 (1%) | 0% | 1.3 | 50,000 | Common Stock |
| Cytosorbents Corp | Bloch P. Kathleen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 13,157 | 13,157 | - | - | Common Stock Warrant (Right to Buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 25 May 2023 | 1,100 | 45,900 (0%) | 0% | 2.8 | 3,123 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 25 May 2023 | 1,100 | 44,800 (0%) | 0% | 2.8 | 3,133 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 25 May 2023 | 1,100 | 47,000 (0%) | 0% | 2.8 | 3,133 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 10 May 2023 | 5,000 | 38,700 (0%) | 0% | 3.1 | 15,298 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 10 May 2023 | 3,000 | 43,700 (0%) | 0% | 3.2 | 9,510 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.12 per share. | 10 May 2023 | 2,000 | 40,700 (0%) | 0% | 3.1 | 6,250 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 215,000 | 215,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 55,500 | 405,161 (1%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 06 Jun 2022 | 8,700 | 33,700 (0%) | 0% | 1.9 | 16,529 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 23 Nov 2021 | 4,000 | 25,000 (0%) | 0% | 5.0 | 19,920 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 69,000 | 69,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 49,450 | 375,372 (1%) | 0% | 9.0 | 444,556 | Common Stock |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 10,000 | 55,650 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Kathleen P. Bloch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 31 Jul 2020 | 10,000 | 325,156 (0%) | 0% | 5.6 | 56,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges